| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |